91 related articles for article (PubMed ID: 2562498)
1. Effect of selenite on the toxicity of cis-DDP in mice: estimation of trace elements.
Shenberg C; Izak-Biran T; Mantel M; Rachmiel B; Weininger J; Chaitchik S
J Trace Elem Electrolytes Health Dis; 1989 Jun; 3(2):71-5. PubMed ID: 2562498
[TBL] [Abstract][Full Text] [Related]
2. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
[TBL] [Abstract][Full Text] [Related]
3. An XRF study of trace elements accumulation in kidneys of tumor-bearing mice after treatment with cis-DDP with and without selenite and selenocistamine.
Shenberg C; Boazi M; Cohen J; Klein A; Kojler M; Nyska A
Biol Trace Elem Res; 1994 Feb; 40(2):137-49. PubMed ID: 7514019
[TBL] [Abstract][Full Text] [Related]
4. Cis DDP in combination with selenium and sulfur. Subcellular effect in kidney cells. Electron microprobe study.
Berry JP; Lespinats G
J Submicrosc Cytol Pathol; 1988 Jan; 20(1):59-65. PubMed ID: 3370622
[TBL] [Abstract][Full Text] [Related]
5. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
Berry JP; Pauwells C; Tlouzeau S; Lespinats G
Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats.
Camargo SM; Francescato HD; Lavrador MA; Bianchi ML
Biol Trace Elem Res; 2001 Dec; 83(3):251-62. PubMed ID: 11794517
[TBL] [Abstract][Full Text] [Related]
8. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
Satoh M; Naganuma A; Imura N
J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
[TBL] [Abstract][Full Text] [Related]
9. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
10. Br/Rb ratio obtained by XRF analysis of kidneys of normal and tumor-bearing mice treated with cis-DDP.
Shenberg C; Boazi M; Cohen J; Klein A; Kojler M; Nyska A; Rave S
J Trace Elem Electrolytes Health Dis; 1994 Dec; 8(3-4):177-82. PubMed ID: 7599509
[TBL] [Abstract][Full Text] [Related]
11. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
Fulco RA; Vannozzi M; Collecchi P; Merlo F; Parodi B; Civalleri D; Esposito M
Anticancer Res; 1990; 10(6):1603-10. PubMed ID: 2285232
[TBL] [Abstract][Full Text] [Related]
12. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
[TBL] [Abstract][Full Text] [Related]
13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
14. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
Satoh M; Naganuma A; Imura N
Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
[TBL] [Abstract][Full Text] [Related]
15. Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum.
Naganuma A; Satoh M; Yokoyama M; Imura N
Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):127-34. PubMed ID: 6685904
[TBL] [Abstract][Full Text] [Related]
16. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.
Ortega R; Moretto P; Fajac A; Benard J; Llabador Y; Simonoff M
Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):77-88. PubMed ID: 8833669
[TBL] [Abstract][Full Text] [Related]
17. [Suppression of CDDP-induced renal toxicity by sodium selenite].
Yokoyama M; Naganuma A; Imura N
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1225-30. PubMed ID: 4057578
[TBL] [Abstract][Full Text] [Related]
18. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
Naganuma A; Satoh M; Imura N
Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
[TBL] [Abstract][Full Text] [Related]
19. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue.
Rizk SL; Sky-Peck HH
Cancer Res; 1984 Nov; 44(11):5390-4. PubMed ID: 6488192
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
